Related Experiment Video
Updated: Oct 24, 2025

Cerebellar Regional Dissection for Molecular Analysis
Published on: December 5, 2020
RNA Toxicity and Perturbation of rRNA Processing in Spinocerebellar Ataxia Type 2
Pan P Li1, Roumita Moulick2, Hongxuan Feng1
1Department of Psychiatry and Behavioral Sciences, Division of Neurobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Background:
Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disease caused by expansion of a CAG repeat in Ataxin-2 (ATXN2) gene. The mutant ATXN2 protein with a polyglutamine tract is known to be toxic and contributes to the SCA2 pathogenesis.
Objective:
Here, we tested the hypothesis that the mutant ATXN2 transcript with an expanded CAG repeat (expATXN2) is also toxic and contributes to SCA2 pathogenesis.
Methods:
The toxic effect of expATXN2 transcripts on SK-N-MC neuroblastoma cells and primary mouse cortical neurons was evaluated by caspase 3/7 activity and nuclear condensation assay, respectively. RNA immunoprecipitation assay was performed to identify RNA binding proteins (RBPs) that bind to expATXN2 RNA. Quantitative PCR was used to examine if ribosomal RNA (rRNA) processing is disrupted in SCA2 and Huntington's disease (HD) human brain tissue.
Results:
expATXN2 RNA induces neuronal cell death, and aberrantly interacts with RBPs involved in RNA metabolism. One of the RBPs, transducin β-like protein 3 (TBL3), involved in rRNA processing, binds to both expATXN2 and expanded huntingtin (expHTT) RNA in vitro. rRNA processing is disrupted in both SCA2 and HD human brain tissue.
Conclusion:
These findings provide the first evidence of a contributory role of expATXN2 transcripts in SCA2 pathogenesis, and further support the role of expHTT transcripts in HD pathogenesis. The disruption of rRNA processing, mediated by aberrant interaction of RBPs with expATXN2 and expHTT transcripts, suggest a point of convergence in the pathogeneses of repeat expansion diseases with potential therapeutic implications. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Insights
Expanded ATXN2 RNA, not just the protein, is toxic in spinocerebellar ataxia type 2 (SCA2). This toxic RNA disrupts RNA processing and interacts with proteins, offering new therapeutic targets for SCA2 and Huntington's disease.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disease linked to expanded CAG repeats in the ATXN2 gene.
- The resulting mutant ATXN2 protein (polyglutamine tract) is known to be toxic, contributing to SCA2 pathogenesis.
Purpose of the Study:
- To investigate the hypothesis that the mutant ATXN2 transcript with an expanded CAG repeat (expATXN2) is also toxic and contributes to SCA2 pathogenesis.
- To explore the role of expATXN2 RNA in neuronal cell death and its interactions with RNA-binding proteins (RBPs).
Main Methods:
- Assessed toxicity of expATXN2 RNA in neuronal cells using caspase 3/7 activity and nuclear condensation assays.
- Utilized RNA immunoprecipitation to identify RBPs binding to expATXN2 RNA.
- Examined ribosomal RNA (rRNA) processing in human brain tissue from SCA2 and Huntington's disease (HD) patients using quantitative PCR.
Main Results:
- expATXN2 RNA was found to induce neuronal cell death.
- Aberrant interactions between expATXN2 RNA and RBPs involved in RNA metabolism were observed.
- Disrupted rRNA processing was identified in both SCA2 and HD human brain tissues, with transducin β-like protein 3 (TBL3) binding to expATXN2 and expanded huntingtin (expHTT) RNA.
Conclusions:
- This study provides the first evidence for a contributory role of expATXN2 transcripts in SCA2 pathogenesis.
- Aberrant RBP interactions with expATXN2 and expHTT transcripts disrupt rRNA processing, suggesting a common pathogenic mechanism in repeat expansion diseases.
- These findings highlight potential therapeutic targets for SCA2, HD, and other repeat expansion disorders.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Nuclear Export of mRNA
piRNA - Piwi-interacting RNAs

